This inventor holds 7 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Tvardi Therapeutics, Inc., Baylor College of Medicine, Tvardi Operating Company, Inc.. Active years: 2021-2026.
Company Filing History:
6 out of 6 
2 out of 617 
1 out of 1 Years Active: 2021-2026
Title: Sofia De Achaval: Innovator in Therapeutic Compounds
Introduction
Sofia De Achaval is a prominent inventor based in Missouri City, TX (US). She has made significant contributions to the field of therapeutic compounds, holding a total of 7 patents. Her work focuses on developing innovative formulations that address critical health issues.
Latest Patents
Sofia's latest patents include groundbreaking advancements in therapeutic compounds and formulations. One notable patent is for compositions and dosage forms that comprise a compound of Formula (I). These compositions may include an emulsifier, a solubilizer, a polyethylene glycol, a surfactant, and an antioxidant. They are particularly useful for treating conditions such as fibrosis, cancer, and chronic inflammation. Another significant patent involves prodrugs of STAT3 inhibitors, which are designed to treat various diseases and disorders, including cancer and chronic inflammation.
Career Highlights
Throughout her career, Sofia has worked with esteemed organizations such as Tvardi Therapeutics, Inc. and Baylor College of Medicine. Her experience in these institutions has allowed her to advance her research and contribute to the development of innovative therapeutic solutions.
Collaborations
Sofia has collaborated with notable professionals in her field, including Imran Alibhai and Tian Zhou. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Sofia De Achaval is a trailblazer in the field of therapeutic compounds, with a strong portfolio of patents that reflect her dedication to improving health outcomes. Her innovative work continues to pave the way for advancements in medical treatments.